======= CDKN2AIP ======= == Gene Information == * **Official Symbol**: CDKN2AIP * **Official Name**: CDKN2A interacting protein * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55602|55602]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NXV6|Q9NXV6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDKN2AIP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDKN2AIP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615914|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene regulates the DNA damage response through several different signaling pathways. One such pathway is the p53-HDM2-p21(WAF1) pathway, which is critical to the DNA damage response. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]. * **UniProt Summary**: Regulates DNA damage response in a dose-dependent manner through a number of signaling pathways involved in cell proliferation, apoptosis and senescence. {ECO:0000269|PubMed:15109303, ECO:0000269|PubMed:24825908}. |DUF3469| |granular component| |p53 binding| |positive regulation of cell growth| |negative regulation of cell growth| |negative regulation of growth| |positive regulation of growth| |regulation of protein stability| |regulation of cell growth| |regulation of growth| |cellular response to DNA damage stimulus| |nucleolus| |RNA binding| |positive regulation of signal transduction| |cellular response to stress| |positive regulation of cell communication| |positive regulation of signaling| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-3.33| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-2.49| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-2.25| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.98| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|-1.94| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.91| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-1.88| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.79| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|1.71| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.74| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|1.75| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.96| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.99| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.54| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13339 * **Expression level (log2 read counts)**: 5.08 {{:chemogenomics:nalm6 dist.png?nolink |}}